VASCULAR BIOGENICS LTD's ticker is and the CUSIP is M96883959. A total of 2 filers reported holding VASCULAR BIOGENICS LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $0 | -100.0% | 100 | -99.0% | 0.00% | – |
| Q4 2022 | $1 | -99.9% | 10,200 | -19.7% | 0.00% | – |
| Q3 2022 | $1,000 | – | 12,700 | +6250.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 200 | -98.2% | 0.00% | – |
| Q3 2021 | $26,000 | -3.7% | 11,400 | 0.0% | 0.00% | – |
| Q2 2021 | $27,000 | – | 11,400 | +1139900.0% | 0.00% | – |
| Q4 2019 | $0 | – | 1 | -50.0% | 0.00% | – |
| Q3 2019 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 2 | -66.7% | 0.00% | – |
| Q1 2019 | $0 | – | 6 | -14.3% | 0.00% | – |
| Q4 2018 | $0 | – | 7 | +16.7% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 6 | -80.0% | 0.00% | – |
| Q2 2018 | $6,000 | -87.5% | 30 | -89.7% | 0.00% | -100.0% |
| Q1 2018 | $48,000 | +700.0% | 290 | +468.6% | 0.00% | – |
| Q2 2017 | $6,000 | +20.0% | 51 | -7.3% | 0.00% | – |
| Q1 2017 | $5,000 | – | 55 | +323.1% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 13 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | +100.0% | 13 | +62.5% | 0.00% | – |
| Q2 2016 | $1,000 | – | 8 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 492 | $117,000 | 0.02% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 17,700 | $42,000 | 0.00% |
| SIMPLEX TRADING, LLC | 11,400 | $27,000 | 0.00% |